Published in Nat Rev Microbiol on July 01, 2010
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature (2010) 2.90
Chikungunya virus, southeastern France. Emerg Infect Dis (2011) 2.88
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog (2011) 1.95
Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol (2012) 1.87
Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog (2011) 1.81
Chikungunya and dengue fever among hospitalized febrile patients in northern Tanzania. Am J Trop Med Hyg (2012) 1.68
Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol (2011) 1.57
Assessing the Epidemic Potential of RNA and DNA Viruses. Emerg Infect Dis (2016) 1.54
Molecular Characterisation of Chikungunya Virus Infections in Trinidad and Comparison of Clinical and Laboratory Features with Dengue and Other Acute Febrile Cases. PLoS Negl Trop Dis (2015) 1.47
Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog (2015) 1.43
Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med (2012) 1.34
SH3 domain-mediated recruitment of host cell amphiphysins by alphavirus nsP3 promotes viral RNA replication. PLoS Pathog (2011) 1.32
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. Vaccine (2011) 1.17
Viperin restricts chikungunya virus replication and pathology. J Clin Invest (2012) 1.16
Dengue and Chikungunya fever among viral diseases in outpatient febrile children in Kilosa district hospital, Tanzania. PLoS Negl Trop Dis (2014) 1.15
A Wolbachia wMel transinfection in Aedes albopictus is not detrimental to host fitness and inhibits Chikungunya virus. PLoS Negl Trop Dis (2013) 1.14
Incubation periods of mosquito-borne viral infections: a systematic review. Am J Trop Med Hyg (2014) 1.14
Chikungunya virus nsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci. J Virol (2012) 1.12
Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol (2012) 1.12
Chikungunya infection in India: results of a prospective hospital based multi-centric study. PLoS One (2012) 1.11
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol (2013) 1.11
Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish. PLoS Pathog (2013) 1.06
Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS One (2012) 1.06
Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol (2014) 1.03
The role of environmental variables on Aedes albopictus biology and chikungunya epidemiology. Pathog Glob Health (2013) 1.03
Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection. PLoS Negl Trop Dis (2014) 1.01
Comparing dengue and chikungunya emergence and endemic transmission in A. aegypti and A. albopictus. J Theor Biol (2014) 1.01
Alphavirus mutator variants present host-specific defects and attenuation in mammalian and insect models. PLoS Pathog (2014) 1.00
Preparedness for threat of chikungunya in the pacific. Emerg Infect Dis (2014) 1.00
Global climate change and its potential impact on disease transmission by salinity-tolerant mosquito vectors in coastal zones. Front Physiol (2012) 1.00
Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry. PLoS Pathog (2013) 0.99
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model. Vaccine (2013) 0.99
Evidence for endemic chikungunya virus infections in Bandung, Indonesia. PLoS Negl Trop Dis (2013) 0.98
A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. J Virol (2014) 0.97
Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy. J Virol (2014) 0.97
Possible impact of rising sea levels on vector-borne infectious diseases. BMC Infect Dis (2011) 0.95
Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis (2013) 0.95
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine. J Virol (2012) 0.95
The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein. J Virol (2011) 0.94
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. PLoS Negl Trop Dis (2013) 0.94
Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2α phosphorylation. Virol J (2013) 0.94
Antiviral activity of silymarin against chikungunya virus. Sci Rep (2015) 0.93
Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm. J Biol Chem (2012) 0.93
Larval development of Aedes aegypti and Aedes albopictus in peri-urban brackish water and its implications for transmission of arboviral diseases. PLoS Negl Trop Dis (2011) 0.93
High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014. Emerg Infect Dis (2016) 0.93
Prime-boost immunization strategies against Chikungunya virus. J Virol (2014) 0.92
A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol (2013) 0.92
Changes in cellular mRNA stability, splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus. Cell Rep (2013) 0.91
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol (2015) 0.91
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest (2017) 0.89
Proteomic analysis of chikungunya virus infected microgial cells. PLoS One (2012) 0.89
Chikungunya virus infection, Brazzaville, Republic of Congo, 2011. Emerg Infect Dis (2013) 0.88
Detection of east/central/south African genotype of chikungunya virus in Myanmar, 2010. Emerg Infect Dis (2014) 0.87
A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice. PLoS Negl Trop Dis (2015) 0.87
Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus. PLoS Negl Trop Dis (2013) 0.87
Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J (2011) 0.87
Chikungunya virus mutation, Indonesia, 2011. Emerg Infect Dis (2015) 0.86
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection. J Infect Dis (2015) 0.86
Rainbow trout (Oncorhynchus mykiss) muscle satellite cells are targets of salmonid alphavirus infection. Vet Res (2016) 0.85
Vector competence of Aedes aegypti and Aedes vittatus (Diptera: Culicidae) from Senegal and Cape Verde archipelago for West African lineages of chikungunya virus. Am J Trop Med Hyg (2014) 0.85
Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. Biomed Res Int (2013) 0.85
DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice. J Infect Dis (2014) 0.85
Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells. PLoS One (2013) 0.84
Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts. PLoS One (2014) 0.84
Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus. PLoS One (2013) 0.84
An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens. PLoS Negl Trop Dis (2014) 0.83
Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection. J Clin Microbiol (2013) 0.82
Chikungunya Virus Replication in Salivary Glands of the Mosquito Aedes albopictus. Viruses (2015) 0.82
Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library. PLoS Negl Trop Dis (2013) 0.82
Structural biology: An alphavirus puzzle solved. Nature (2010) 0.82
Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus. J Mol Model (2014) 0.82
Inflammatory biomarkers, disease activity index, and self-reported disability may be predictors of chronic arthritis after chikungunya infection: brief report. Clin Rheumatol (2016) 0.81
Comprehensive proteomic analysis of white blood cells from chikungunya fever patients of different severities. J Transl Med (2014) 0.81
Cell-based analysis of Chikungunya virus E1 protein in membrane fusion. J Biomed Sci (2012) 0.81
Neuropathogenesis of Chikungunya infection: astrogliosis and innate immune activation. J Neurovirol (2015) 0.81
The interaction of alphavirus E1 protein with exogenous domain III defines stages in virus-membrane fusion. J Virol (2011) 0.81
Seroprevalence of Chikungunya Virus in a Rural Community in Brazil. PLoS Negl Trop Dis (2017) 0.81
The Usual Suspects: Comparison of the Relative Roles of Potential Urban Chikungunya Virus Vectors in Australia. PLoS One (2015) 0.80
A key interaction between the alphavirus envelope proteins responsible for initial dimer dissociation during fusion. J Virol (2013) 0.80
CXCR4: a virus's best friend? Infect Genet Evol (2014) 0.80
Residue-level resolution of alphavirus envelope protein interactions in pH-dependent fusion. Proc Natl Acad Sci U S A (2015) 0.80
Chikungunya fever: focus on peripheral markers of pathogenesis. J Infect Dis (2011) 0.80
Studying the immune response to human viral infections using zebrafish. Dev Comp Immunol (2014) 0.80
Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells. Virol J (2012) 0.80
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. Biomed Res Int (2013) 0.80
Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway. J Nat Prod (2016) 0.79
Chikungunya virus capsid protein contains nuclear import and export signals. Virol J (2013) 0.79
Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences. Virus Evol (2017) 0.79
Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses. Viruses (2016) 0.78
Crystal structure of aura virus capsid protease and its complex with dioxane: new insights into capsid-glycoprotein molecular contacts. PLoS One (2012) 0.78
Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates. Biosci Rep (2015) 0.78
Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus. Parasit Vectors (2015) 0.78
Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine. J Chromatogr A (2014) 0.78
Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virol J (2016) 0.78
Two-Color Lateral Flow Assay for Multiplex Detection of Causative Agents Behind Acute Febrile Illnesses. Anal Chem (2016) 0.78
DNA-launched live-attenuated vaccines for biodefense applications. Expert Rev Vaccines (2016) 0.78
Regulation of Viral Replication, Apoptosis and Pro-Inflammatory Responses by 17-AAG during Chikungunya Virus Infection in Macrophages. Viruses (2017) 0.77
ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence. Proc Natl Acad Sci U S A (2017) 0.77
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 22.65
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 16.26
Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci (1957) 13.46
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol (2007) 12.00
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med (2006) 11.14
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
Chikungunya, an epidemic arbovirosis. Lancet Infect Dis (2007) 7.87
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Present and future arboviral threats. Antiviral Res (2009) 6.57
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 6.37
Virus entry: open sesame. Cell (2006) 6.33
IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science (1997) 6.30
Innate recognition of viruses. Immunity (2007) 6.21
Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol (2001) 6.19
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol (2008) 6.17
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol (2007) 6.16
Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med (2009) 5.77
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature (2005) 5.32
Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis (2007) 5.16
Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One (2007) 4.95
An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg (1955) 4.94
An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg (1955) 4.83
Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis (2009) 4.72
A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg (2007) 4.18
Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol (2006) 4.16
Aedes albopictus in North America: probable introduction in used tires from northern Asia. Science (1987) 4.12
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature (2004) 4.02
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol (2003) 3.97
Tracking the re-emergence of epidemic chikungunya virus in Indonesia. Trans R Soc Trop Med Hyg (2005) 3.74
Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg (1999) 3.56
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40
Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J (2008) 3.39
Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect (2009) 3.25
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol (2003) 3.19
Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol (2005) 3.18
Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain. J Med Virol (2004) 2.94
Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med (2003) 2.92
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Evolutionary relationships and systematics of the alphaviruses. J Virol (2001) 2.84
Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals. J Bacteriol (1966) 2.78
Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol (2000) 2.67
Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol (2010) 2.64
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis (2008) 2.61
Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55
Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis (2009) 2.54
Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg (2008) 2.53
Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med (2008) 2.49
Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One (2007) 2.47
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol (2007) 2.46
Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis (2007) 2.44
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg (2000) 2.39
Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J (1983) 2.38
Impact of climate change and other factors on emerging arbovirus diseases. Trans R Soc Trop Med Hyg (2008) 2.33
The interferon antiviral response: from viral invasion to evasion. Curr Opin Infect Dis (2002) 2.33
The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol (2006) 2.22
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med (2008) 2.21
Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis (2008) 2.09
IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One (2009) 2.04
Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev (2001) 2.00
Chikungunya fever. Lancet (2006) 1.97
Precipitation and temperature effects on populations of Aedes albopictus (Diptera: Culicidae): implications for range expansion. J Med Entomol (2001) 1.89
Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J Gen Virol (2008) 1.86
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood (2006) 1.83
An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg (2008) 1.83
Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine (1986) 1.74
Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol (2006) 1.73
The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue. Trans R Soc Trop Med Hyg (1969) 1.70
Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell (2003) 1.67
Neurologic manifestations of pediatric chikungunya infection. J Child Neurol (2008) 1.66
Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006. Euro Surveill (2006) 1.64
Chikungunya infection in neonates. Indian Pediatr (2008) 1.61
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol (2010) 1.60
Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells. J Virol (2005) 1.59
Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. Clin Chem (2007) 1.58
Temperature effects on the dynamics of Aedes albopictus (Diptera: Culicidae) populations in the laboratory. J Med Entomol (2001) 1.58
The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbiol (2008) 1.56
The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus (2008) 1.53
Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. J Virol (2000) 1.52
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Europe witnesses first local transmission of chikungunya fever in Italy. BMJ (2007) 1.47
Host responses to alphavirus infection. Immunol Rev (2008) 1.46
Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect Biochem Mol Biol (2005) 1.45
Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol (2009) 1.43
Semliki Forest virus nonstructural protein 2 is involved in suppression of the type I interferon response. J Virol (2007) 1.41
Resurgence of chikungunya virus in India: an emerging threat. Euro Surveill (2006) 1.36
Production and evaluation of a formalin-killed Chikungunya vaccine. J Immunol (1971) 1.35
Outbreak news. Chikungunya, India. Wkly Epidemiol Rec (2006) 1.32
Effect of interferon on early interferon production. Science (1966) 1.30
Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes. Am J Trop Med Hyg (2005) 1.30
Chikungunya: a risk for Mediterranean countries? Acta Trop (2007) 1.28
Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science (1970) 1.27
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature (2011) 6.29
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog (2008) 3.40
Characterization of reemerging chikungunya virus. PLoS Pathog (2007) 3.22
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest (2010) 2.43
Innate sensing of HIV-infected cells. PLoS Pathog (2011) 2.22
Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nat Med (2011) 2.14
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood (2005) 2.01
Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis (2013) 1.86
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med (2010) 1.86
Visualizing the functional diversification of CD8+ T cell responses in lymph nodes. Immunity (2010) 1.85
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. Blood (2010) 1.81
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med (2005) 1.71
Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med (2007) 1.48
The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res (2004) 1.37
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol (2005) 1.35
Chikungunya virus-induced autophagy delays caspase-dependent cell death. J Exp Med (2012) 1.34
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood (2003) 1.33
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis (2005) 1.31
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Immune response against dying tumor cells. Adv Immunol (2004) 1.26
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease. J Infect Dis (2009) 1.22
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med (2007) 1.20
Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog (2013) 1.15
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol (2006) 1.13
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood (2006) 1.13
Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J Immunol (2012) 1.04
Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity. Immunity (2011) 1.00
Litchi-associated acute encephalitis in children, Northern Vietnam, 2004-2009. Emerg Infect Dis (2012) 1.00
Simultaneous assessment of autophagy and apoptosis using multispectral imaging cytometry. Autophagy (2011) 0.98
Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J Immunol (2011) 0.94
Dissecting T cell contraction in vivo using a genetically encoded reporter of apoptosis. Cell Rep (2012) 0.93
Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood (2012) 0.93
Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection. Hepatology (2014) 0.92
CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients. Cytokine (2013) 0.89
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS One (2010) 0.88
Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming. J Immunol (2008) 0.87
The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis. Hepatology (2014) 0.86
Orchestration of the immune response by dendritic cells. Curr Biol (2009) 0.86
Cutting edge: cross-presented intracranial antigen primes CD8+ T cells. J Immunol (2007) 0.85
Gamma c cytokines condition the progressive differentiation of CD4+ T cells. Proc Natl Acad Sci U S A (2007) 0.84
Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus. J Virol (2011) 0.83
Chikungunya-induced cell death is limited by ER and oxidative stress-induced autophagy. Autophagy (2012) 0.83
Antigen Cross-Priming of Cell-Associated Proteins is Enhanced by Macroautophagy within the Antigen Donor Cell. Front Immunol (2012) 0.82
Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response. Oncoimmunology (2012) 0.82
The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity. Immunol Rev (2013) 0.81
Signal 0 for guided priming of CTLs: NKT cells do it too. Nat Immunol (2010) 0.81
A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes. J Virol (2012) 0.80
Interferon induced protein 10 remains a useful biomarker of treatment failure in patients stratified for the interleukin-28B rs12979860 haplotype. Hepatology (2011) 0.79
Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery. Front Immunol (2011) 0.79
A whodunit: an appointment with death. Curr Opin Immunol (2010) 0.79
Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype. J Infect Dis (2010) 0.77
Tracking antigen-specific CD8⁺ T cells using MHC class I multimers. Methods Mol Biol (2013) 0.76
BCG-mediated bladder cancer immunotherapy: identifying determinants of treatment response using a calibrated mathematical model. PLoS One (2013) 0.76